'New day' in lung cancer as Merck drug shines, works with chemo

Facebook
VKontakte
share_fav

Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.

view Fox News: Most Popular